Abreos Biosciences Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Abreos Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10362
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abreos Biosciences Inc (Abreos) is a biotechnology company with focus on the development of laboratory-based and point-of-care (POC) assays and reagents for the precision dose monitoring of biologic drugs. Its Monator, is a drug-monitoring test that provides physicians with vital information for the personalized treatment of multiple sclerosis using natalizumab. The company developed a veritope technology platform to identify proprietary peptide-based ligands that can measure and purify biologic molecules. Its Veritopes can be customized for use in multiple formats including sandwich ELISA for the direct tracking of blood concentrations of biologic drugs. Abreos offers custom reagents to biopharmaceutical manufacturers and researchers for drug development life cycle; pharmacokinetic studies; bio-purification; and personalized dosing of biologic drugs. Abreos is headquartered in San Diego, California, the US.

Abreos Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abreos Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abreos Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abreos Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abreos Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Abreos Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abreos Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Abreos Biosciences Raises USD1.2 Million in Financing 10
Abreos Biosciences Raises USD0.1 Million in Venture Financing 11
Abreos Biosciences Raises USD0.7 Million in Seed Financing 12
Abreos Biosciences Raises USD0.2 Million in Venture Financing 13
Partnerships 14
Abreos Biosciences and Institut Paoli-Calmettes Enter into Research Collaboration 14
Abreos Biosciences Enters into Co-Development Agreement with True Diagnostics 15
Abreos Biosciences Inc – Key Competitors 16
Abreos Biosciences Inc – Key Employees 17
Abreos Biosciences Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Jan 24, 2018: Abreos Biosciences Wins Promising Company Award at the Precision Medicine World Conference 2018 19
Sep 26, 2017: Abreos Biosciences competed as a finalist in the MedTech Innovator 2017 Competition 20
Government and Public Interest 22
May 31, 2017: MedTech Innovator Announces Startups Selected for Industry’s Premier Accelerator 22
Other Significant Developments 23
Jun 20, 2018: Abreos Biosciences and LifeAssays sign R & D agreements for cancer and autoimmune tests in human medicine 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Abreos Biosciences Inc, Medical Equipment, Key Facts 2
Abreos Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Abreos Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abreos Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abreos Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abreos Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Abreos Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abreos Biosciences Raises USD1.2 Million in Financing 10
Abreos Biosciences Raises USD0.1 Million in Venture Financing 11
Abreos Biosciences Raises USD0.7 Million in Seed Financing 12
Abreos Biosciences Raises USD0.2 Million in Venture Financing 13
Abreos Biosciences and Institut Paoli-Calmettes Enter into Research Collaboration 14
Abreos Biosciences Enters into Co-Development Agreement with True Diagnostics 15
Abreos Biosciences Inc, Key Competitors 16
Abreos Biosciences Inc, Key Employees 17

List of Figures
Abreos Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Abreos Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Abreos Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Abreos Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Abreos Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abreos Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Abreos Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abreos Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Abreos Biosciences Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dow Jones & Co Inc:企業の戦略的SWOT分析
    Dow Jones & Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Sonic Corp.:企業の戦略・SWOT・財務情報
    Sonic Corp. - Strategy, SWOT and Corporate Finance Report Summary Sonic Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • iNova Pharmaceuticals (Australia) Pty Ltd:企業の戦略的SWOT分析
    iNova Pharmaceuticals (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Desjardins Financial Security Life Assurance Company:企業の戦略・SWOT・財務情報
    Desjardins Financial Security Life Assurance Company - Strategy, SWOT and Corporate Finance Report Summary Desjardins Financial Security Life Assurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • Moldex-Metric Inc:企業の戦略的SWOT分析
    Moldex-Metric Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Opsona Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Opsona Therapeutics Ltd (Opsona) is a drug developing company that conducts research, develops and commercializes new treatment for the autoimmune and inflammatory diseases and cancers. The company's OPN-305 is a humanized antibody used to reduce pro-inflammatory cytokine production that is …
  • GP Reinsurance EAD:企業の戦略的SWOT分析
    GP Reinsurance EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Forty Seven Inc (FTSV):製薬・医療:M&Aディール及び事業提携情報
    Summary Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead molecule Hu5F9-G4 is a monoclonal antibody that is used against the CD47 receptor. Its monoclonal antibody is …
  • Accenture plc:企業のM&A・事業提携・投資動向
    Accenture plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Accenture plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • The E. W. Scripps Company (SSP):企業の財務・戦略的SWOT分析
    The E. W. Scripps Company (SSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • SS&C Technologies Holdings Inc.:企業のM&A・事業提携・投資動向
    SS&C Technologies Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SS&C Technologies Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • The Bank Of East Asia, Limited:企業の戦略・SWOT・財務分析
    The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Celulose Nipo-Brasileira SA:企業の戦略的SWOT分析
    Celulose Nipo-Brasileira SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • The Vanguard Group Inc:企業の戦略的SWOT分析
    The Vanguard Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Argent Trading Llc:企業の戦略・SWOT・財務分析
    Argent Trading Llc - Strategy, SWOT and Corporate Finance Report Summary Argent Trading Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Meridian Bioscience Inc (VIVO)-医療機器分野:企業M&A・提携分析
    Summary Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, a …
  • ManTech International Corporation:企業の戦略・SWOT・財務情報
    ManTech International Corporation - Strategy, SWOT and Corporate Finance Report Summary ManTech International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • FAR Ltd (FAR):石油・ガス:M&Aディール及び事業提携情報
    Summary FAR Ltd (FAR), formerly First Australian Resources NL, is an independent oil and gas company that offers acquisition, exploration, production and development of oil and natural gas properties. The company has oilfield appraisal wells and exploration assets in West and East Africa. It operate …
  • Srei Infrastructure Finance Ltd:企業の戦略・SWOT・財務分析
    Srei Infrastructure Finance Ltd - Strategy, SWOT and Corporate Finance Report Summary Srei Infrastructure Finance Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Curevac AG-製薬・医療分野:企業M&A・提携分析
    Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical stage biopharmaceutical company that develops RNA-based medicines. The company designs, develops and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RNA …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆